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Epinephrine (EPI) is a hormone that triggers body alarm systems and a stress 
context in all body. Phenylethanolamine-N-methyltransferase-knock-out (Pnmt-
KO) mice are unable to synthetize EPI and present reduced contextual-fear, 
suggesting that EPI deficiency selectively affects contextual-fear memory. Our 
aim was to understand the pathway by which EPI increases contextual-fear 
memory. In addition, we also evaluated if time erases EPI-mediated fear 
memory or if this memory persists as old memories. Another aim was to 
understand if β2-adrenoceptor (AD) antagonists could erase traumatic 
contextual memories. Finally, we propose a possible pharmacological therapy 
for traumatic memories in anxiety disorders, in particular in post-traumatic 
stress disorder (PTSD). 
Wild type (WT) and Pnmt-KO (129x1/SvJ) male mice were submitted to fear 
conditioning procedure after specific treatments with EPI, β-AD agonists 
(isoprenaline and fenoterol), and antagonists (sotalol and ICI 118,551). The 
experiments were evaluated on day one (fear acquisition) and day two (context 
fear test, long-term memory), and some experiments one month after fear 
acquisition (context fear test, old memories). The catecholamines were 
separated by reverse-phase HPLC, and quantified by electrochemical detection. 
Blood glucose was measured by coulometry. 
We showed that EPI selectively affects contextual-fear memory and not sound 
fear memory. In addition, EPI increases contextual-fear memory, both one day 
(long-term memory) and one month after fear acquisition (old memories). The 
mechanism by which EPI influences contextual-fear memory appears to be 
through peripheral β2-AD activation. In addition, glucose may be a major EPI 
downstream mediator in contextual-fear memory. In WT mice, plasma EPI 
concentration was significantly higher after fear acquisition test compared with 
mice without the test. ICI 118,551 (β2-AD antagonist) decreased contextual-fear 
memory in WT mice, in both one day and one month after fear acquisition. 
In conclusion, EPI increases in plasma after an aversive experience, possibly 
improving long-term contextual-fear memory, and even old memories, by acting 
on peripheral β2-ADs. We suggest that blocking β2-ADs with antagonists may 
inhibit undesirable memories and may be used as a treatment for patients 
suffering from pathogenic memories, such as PTSD. 
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A epinefrina (EPI) é uma hormona que aciona sistemas de alarme e um 
contexto de stresse por todo o corpo. Os ratinhos deficientes em 
feniletanolamina-N-metiltransferase (Pnmt-KO) não sintetizam EPI e 
apresentam a memória do medo contextual reduzida, sugerindo que a 
deficiência de EPI afeta seletivamente a memória contextual do medo. O 
nosso objetivo foi perceber a via pela qual a EPI aumenta a memória 
contextual do medo. Além disso, também avaliamos se o tempo apaga a 
memória de medo mediada pela EPI ou se essa memória persiste. Outro 
objectivo foi perceber se os antagonistas dos recetores adrenérgicos β2 
permitem apagar memórias traumáticas contextuais antigas. Finalmente 
propomos uma possível terapia farmacológica para memórias 
traumáticas nas patologias de ansiedade, em particular na síndrome de 
stresse pós-traumático (PTSD). 
Os ratinhos do tipo selvagem (WT) e Pnmt-KO (129x1 / SvJ) foram 
submetidos ao procedimento de condicionamento do medo após 
tratamentos específicos com EPI e agonistas (isoprenalina e fenoterol) e 
antagonistas (sotalol e ICI 118,551) dos recetores adrenérgicos β. As 
experiências foram avaliadas no primeiro dia (aquisição de medo) e no 
segundo dia (teste contextual de medo, memória a longo prazo), e 
algumas experiências um mês após a aquisição do medo (teste 
contextual de medo, memórias antigas). As catecolaminas foram 
separadas por HPLC de fase reversa e quantificadas por detecção 
electroquímica. A glicemia foi medida por colometria. 
Nós mostramos que a EPI afeta seletivamente a memória contextual do 
medo e não a memória auditiva do medo. Além disso, a EPI aumenta a 
memória do medo contextual, um dia (memória de longo prazo) e um 
mês após a aquisição do medo (memórias antigas). O mecanismo pelo 
qual a EPI influencia a memória do medo contextual parece ser através 
da ativação de recetores adrenérgicos β2 periféricos. Além disso, a 
glicose pode ser um importante mediador da EPI a jusante, na memória 
contextual do medo. Nos ratinhos WT, a concentração plasmática de EPI 
foi significativamente maior após o teste de aquisição de medo 
comparativamente com ratos sem o teste. O ICI 118,551 (antagonista dos 
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recetores adrenérgicos β2) diminui a memória de medo contextual em 
ratinhos WT, tanto um dia como um mês após a aquisição do medo. 
Em conclusão, a EPI aumenta no plasma após uma experiência aversiva, 
possivelmente melhorando a memória do medo contextual a longo prazo 
e até memórias antigas, atuando sobre recetores adrenérgicos β2 
periféricos. Nós sugerimos que o bloqueio de recetores adrenérgicos β2 
com antagonistas pode inibir memórias traumáticas e ser usado como um 
tratamento para doentes que sofrem de memórias patogénicas, como é o 
caso da PTSD. 
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1) Learning and memory 
A very large amount of evidence suggests that norepinephrine (NE) and 
epinephrine (EPI) signaling facilitate cognitive processes such as learning and 
memory (King and Williams 2009). Learning commonly refers to acquisition of 
information, such as learning a new word list. In humans, it is usually evaluated 
using an immediate recall test. On the other hand, memory is the process by 
which information is encoded, stored and retrieved. There are two types of 
memory, the declarative (explicit) and the non-declarative (implicit) memory 
(Elzinga and Bremner 2002). 
 
1.1) Declarative memory 
Declarative memory encompasses the storage of consciously learned facts, and 
comprises both semantic and episodic knowledge (Gabrieli et al. 1988). 
Episodic memory generally lures upon semantic knowledge, and over time with 
repetition becomes semantic knowledge. Most standard verbal and visual 
neuropsychological memory tests evaluate episodic declarative memory. 
Intense research in this area suggests that the hippocampus, rhinal cortex, and 
areas of the neo-cortex all play an important role in declarative memory (Elzinga 
and Bremner 2002). 
 
1.2) Non-declarative memory 
Non-declarative memory (or implicit memory) comprises the incidental 
acquisition of new knowledge and is frequently tested with priming tasks. Non-
declarative memory also includes the acquisition of new behaviors or skills 
through recurrent exposures or trials (procedural memory and motor skills) and 
associative learning (classical and operant conditioning, and related contextual 
memory). Evidence suggests that the hippocampus and the amygdala are 
essential for associative learning (Kim and Jung 2006). 
Non-declarative memory, in particular associative learning, can be tested by 
pairing one stimulus with another, and later evaluate whether a subject has 
learned to make the association between two stimuli. An example is classical or 
Pavlovian conditioning, which is a paradigm developed by the Russian 
physiologist Pavlov.  In classical conditioning, a novel stimulus (conditioned 
stimulus, CS; for example sound) is paired with an unconditioned stimulus (US; 
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for example food) that usually elicits a reflexive response (unconditioned 
response, UR; for example salivation). After appropriate training with contingent 
CS-US presentations, the CS is capable of provoking a response (conditioned 
response, CR), which often resembles the UR. 
 
1.2.1) Fear Conditioning 
Fear conditioning is a behavioral paradigm in which animals learn to forecast 
aversive events. Fear is considered a self-protective mechanism that developed 
because of its success in protecting animals from threats. While fear due to 
certain types of stimuli is innately hardwired, fear can also be learned quickly 
and enduringly to different stimuli, allowing animals to respond adaptively to 
changing environmental conditions (Kim and Jung 2006). Fear conditioning is 
frequently used in associative learning, in which memory for a context-shock 
association is stabilized via hippocampal-dependent consolidation processes, 
and memory for a sound-shock association is stabilized through amygdala-
dependent consolidation processes (Bergstrom et al. 2013). 
In fear conditioning procedure, the CS, such as a context, is paired with an 
aversive US, such as an electric shock. After numerous shocks in the same 
context, it is produced an involuntary response, such as freezing in presence of 
the context (in absence of the shock) (Fanselow 1980). Some studies show that 
the association between the context and shock is vigorous and long lasting 
(LeDoux 2000). 
 
2) Emotional arousal 
Emotional arousal produced by aversive stressors results in the release of 
glucocorticoids and catecholamines (EPI and NE) from the adrenal glands and 
influence memory (Roozendaal 2002). In humans, emotional stimulus are better 
remembered than neutral stimulus owed to actions of adrenal hormones 
(glucocorticoids, EPI, NE) (Akirav 2013). 
The hypothalamic-pituitary-adrenal (HPA) axis coordinates the stress response. 
Upon exposure to stress, neurons in the hypothalamic paraventricular nucleus 
(PVN) secrete corticotropin-releasing hormone (CRH) from nerve terminals into 
circulation, which stimulates the synthesis and release of adrenocorticotropin 
hormone (ACTH) from the anterior pituitary. ACTH in turn stimulates the release 
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of glucocorticoids from the adrenal cortex. Glucocorticoids orchestrate 
physiologic behavior to handle stressors (Smith and Vale 2006). 
 
2.1) Corticosteroids and catecholamines 
Glucocorticoid and EPI are important stress hormones secreted from the 
adrenal gland. The adrenal glucocorticoids may stimulate phenylethanolamine-
N-methyltransferase (PNMT) to convert NE to EPI in the adrenal medulla. On 
the other hand, by suppressing adrenal glucocorticoid production it might also 
reduce the secretion of EPI (Munck et al. 1984). 
Drugs that increase plasma concentrations of glucocorticoids or catecholamines 
during, or following learning improve memory in mice and rats (Krugers et al. 
2012). A very large amount of evidence suggests that NE and EPI signaling 
facilitate cognitive processes (Cahill and Alkire 2003). However, the specific role 
of EPI in memory is less known, because of the difficulty in distinguishing the 
effects of EPI from those of NE.  
 
3) Adrenal gland 
 
3.1) Adrenal gland overview 
The adrenal glands are located just medial to the upper pole of each kidney. 
Each adrenal gland consists of an inner medulla (produces EPI and NE) and an 
outer cortex (produces steroid hormones). The medulla and cortex differ in 
embryological origin, structure, and function. The medulla develops from neural 
crest tissue and the cortex from mesoderm (Rosol et al. 2001). 
The adrenal medulla is constituted by groups of chromaffin cells filled with 
catecholamine granules, which stock large amounts of EPI and NE. The adrenal 
cortex is made up of sheets of cells surrounded by capillaries. It is arranged in 
three zones: the outer zone glomerulosa (synthesis of aldosterone), middle 
zone fasciculate (synthesis of cortisol), and inner zone reticularis (synthesis of 
androgens) (Rosol et al. 2001). 
The adrenal gland is abundantly vascularised and obtains its chief arterial 
supply from branches of the inferior phrenic artery, renal arteries and the aorta. 
These small arteries form an arterial plexus beneath the capsule surrounding 
the adrenal and then enter a sinusoidal system that enters the cortex and the 
medulla draining into a single central adrenal vein. The veins drain to the 
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inferior vena cava and the renal vein. The blood supply is not reduced during 
stress (Rosol et al. 2001). 
 
3.2) Catecholamines and Enzymes 
Tyrosine hydroxylase (TH) catalyzes the formation of 3, 4-
dihydroxyphenylalanine (L-dopa) from L-tyrosine. TH is the rate-limiting enzyme 
in catecholamine biosynthesis, it is regulated by a wide array of physiological 
mechanisms. These mechanisms are short or long-term and include 
phosphorylation, feedback inhibition by catecholamines and regulation of mRNA 
and protein synthesis (Zhang et al. 2014). Then aromatic L-amino acid 
decarboxylase (AADC) synthesizes dopamine with L-dopa as substrate. These 
two enzymes are present in all catecholamine-producing cells. Dopamine β-
hydroxylase (DBH) catalyzes the hydroxylation of dopamine to NE. This 
enzyme is present in both NE and EPI producing cells. Finally, PNMT is the 
methyltransferase that catalyzes the formation of EPI from NE and occurs 
mainly in EPI-producing cells. The catecholamine phenotype is determined by 
the specific cell type and harmonized expression of the genes encoding the 
catecholamine-synthesizing enzymes (Nagatsu 2006). 
 
3.3) Receptors 
EPI and NE act at adrenoceptors (ADs). ADs are G protein coupled receptors. 
β-ADs are divided in β1 (heart, blood vessels…), β2 (bronchi, blood vessels…) 
and β3 (fat…). The relative potency of EPI and NE at βADs is for β1, EPI=NE 
and for β2, EPI>>NE. α-ADs are divided in α1, (blood vessels, gut sphincters…) 
and α2 (presynaptic terminals…). (MacGregor et al. 1996). 
 
3.4) Adrenalectomy 
Manuscripts showing the adverse effects of adrenalectomy (ADX) on memory 
provide evidence for the importance of corticosteroids and catecholamines in 
animal cognition. The elimination of the adrenal glands causes a dramatic 
reduction in endogenous circulating corticosterone and catecholamines. 
Adrenalectomized rats submitted to the Morris water maze show impaired 
spatial memory for the platform location, which was reversed by 
dexamethasone supplementation (Roozendaal et al. 1996). These rats also 
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show deficiencies in associative learning tasks, such as passive avoidance 
(Borrell et al. 1983) and acquired immobility response (Peeters et al. 1992). It is 
important to understand that no impairment was observed when only the 
adrenal medulla was removed (thus sparing the adrenal cortex and endogenous 
corticosterone levels)(Oitzl et al. 1995), however residual adrenal medulla could 
be sufficient to produce catecholamines. In addition, memory deficits detected 
resulting of ADX, which relentlessly depletes peripheral concentrations of EPI 
and glucocorticoids, were reversed by the infusion of NE into the amygdala 
(Liang et al. 1986). These studies provide evidence of the modulatory effects of 
corticosteroids and catecholamines on animal cognition (Mizoguchi et al. 2004). 
It has been problematic to decode the role of catecholamines with the frequently 
used adrenal medullectomy because this process can harm the adrenal cortex, 
changing the release of corticosteroids, and it eliminates the release of other 
adrenal amines and peptides, such as NE, chromogranin A, catestatin and 
neuropeptide (Harrison and MacKinnon 1966). 
 
3.5) Knock-out mice 
Studies with knockout mice have been important in the identification of novel 
molecular mechanisms in learning and memory (Nguyen et al. 2000). Dopamine 
β-hydroxylase knockout mice (unable to synthesize both NE and EPI) exhibit 
reduced contextual-fear memory. Poor conditioned fear in these mice was 
restored by β-AD agonist isoprenaline (Murchison et al. 2004). However, the 
inquiry continued whether reduced contextual-fear memory is due to the 
absence of both catecholamines (NE and EPI) or if lack of EPI only could create 
this phenotype. Therefore, the precise part of EPI in these processes is less 
known, because of the difficulty in differentiating the effects of NE from those of 
EPI. 
Another method is the use of Pnmt inhibitors to block the EPI synthesis in vivo, 
but most of them also hinder monoamine oxidase and β2-ADs (Bondinell et al. 
1983). These disadvantages for the clarification of the specific role of EPI on 
fear learning are avoided by using an EPI deficient mice model produced by 
knocking out the Pnmt gene (Ebert et al. 2004). 
The Pnmt knockout (Pnmt-KO) mouse model (Pnmt−/−) used in these studies 
was originally designed to evaluate the distribution of adrenergic cells by Ebert 
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and coworkers (Ebert et al. 2004). The Cre-recombinase gene was inserted into 
the mouse Pnmt locus, disrupting the functional expression of Pnmt (Ebert et al. 
2004) .The targeted disruption of the Pnmt gene led to the creation of mice that 
were deficient in their capability to produce EPI. It is likely that the absence of 
EPI in Pnmt-KO mice will provoke some adaptive changes in the metabolism of 
catecholamines. Nevertheless, these mice were still able to produce NE. In fact, 
increased levels of NE have been found in adrenal glands of the Pnmt-KO mice 
(Ebert et al. 2004). 
There were no gross apparent developmental defects in homozygous mice 
lacking EPI. In addition, they persisted to adulthood, were physically 
indistinguishable from wild type (WT) and heterozygous littermates and were 
able to breed efficiently (Ebert et al. 2004). Thus, these mice are a model for 
investigating the physiologic action of EPI. Afterwards, Toth et al (Toth et al. 
2013) showed that Pnmt-KO mice presented reduced contextual-fear learning, 
suggesting that EPI deficiency selectively affects contextual-fear memory and 
these mice exhibit less selective memory effects on highly emotional memories. 
 
3.6) Influence of peripheral epinephrine in the brain 
Peripheral EPI increases under highly arousing states (Chen and Williams 
2012). Since EPI does not pass from the peripheral circulation into the brain, 
there must be mechanisms that allow the influence of EPI in the brain. There 
are two major hypotheses about EPI specific pathway in influencing memory. 
Electrophysiological and pharmacological studies suggest that the effect of EPI 
on memory and in facilitating NE output in the amygdala may be initiated by the 
stimulation of peripheral vagal fibers that project to the brain (McIntyre et al. 
2012). Chen et al showed simultaneously that the intraperitoneal injection of 
EPI (0.3 mg/Kg) lead to the increasing firing discharge along afferent fibers of 
the vagus nerve mediated through β-ADs and this was accompanied by 
increases in extracellular concentration of NE in the basolateral amygdala 
(Chen and Williams 2012). The information is conducted by ascending vagal 
fibers to the nucleus of the solitary tract (NTS) situated in the brainstem. The 
memory-modulating EPI effects causes glutamatergic release in the NTS, 
stimulates locus coeruleus and noradrenergic release in the amygdala and 
hippocampus. Pharmacological studies show that the blockade of NTS 
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glutamatergic receptors attenuates the enhancement in memory produced by 
EPI injections (King and Williams 2009). 
The other hypothesis is centered in glucose, which is released into the blood 
after activation of hepatic ADs by EPI (Gold 2014). Maintenance of glucose 
supply to the brain is a primacy for basic brain processes. Therefore, the brain 
is a chief consumer of glucose during stress, and the fact that the brain has only 
insignificant energy reserves makes it critically reliant on the supply from the 
periphery. Memory formation is limited by the hippocampus glucose supply that 
regulates the ability to form memories. Administration of glucose, either 
peripherally or directly to the hippocampus, can increase memory in a dose-
dependent way (Messier 2004). 
 
4) Potential clinical applications 
The importance of this study is further enhanced due to the knowledge that in 
anxiety disorders contextual factors contribute to fear generalization, traumatic 
memory retrieval and relapse after exposure therapy (Mineka et al. 1999). 
Therefore, the mechanisms that lie beneath the retrieval of emotional 
associations due to context may have implications for the study and treatment 
of anxiety disorders. 
The findings on memory consolidation have generated unlimited attention in the 
medical community, particularly among those who treat disorders that are 
based on pathogenic memories. Since post-traumatic stress disorder (PTSD) is 
characterized by the existence of strong and recurrently recalled memories 
(Alberini 2011), it could benefit from targeting memory consolidation, as a 
possible therapeutic approach. On the other hand, traumatic exposure is known 
to increase the risk for depression, phobias, panic disorder, obsessive-
compulsive disorder and addiction (Dohrenwend 2000). 
PTSD is an incapacitating and chronic disorder resulting from exposure to life 
frightening trauma and stress. It is frequently associated with shocking wartime 
experiences, but it affects both military persons and civilians (Ursano et al. 
2016). The PTSD prevalence in the world is 2%-20% depending on the country 
and exposure to life-threatening events (Atwoli et al. 2015). In PTSD, the 
traumatic event (US) causes a robust hormonal stress response, which 
facilitates the development of a strong and enduring memory of the trauma 
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(UR). Subsequent recall of the event (CR) in reply to cues and reminders (CS) 
releases additional stress hormones. This may even promote consolidation of 
memory, leading to PTSD symptoms such as flashbacks, nightmares, and 
anxiety (Pitman and Delahanty 2005). The persistence of PTSD can be clarified 
in terms of trauma-induced consolidation of the memory trace. In fact, it is 
hypothesized that noradrenergic hyperactivity and stress hormones facilitate 
encoding and consolidation (O'Donnell et al. 2004). 
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Toth et al showed reduced contextual-fear learning in Pnmt-KO mice, 
suggesting that EPI deficiency selectively affects contextual-fear learning (Toth 
et al. 2013). However, they did not explain the mechanism responsible for the 
impaired contextual-fear memory in these mice. In view of this, one aim was to 
evaluate contextual-fear memory with EPI treatment in Pnmt-KO and WT mice. 
Another aim was to understand the pathway by which EPI increases contextual-
fear memory using β-AD agonists and antagonists. In addition, we also 
evaluated if time erases EPI-mediated fear memory or if this memory persists in 
the long-term, and even as old memories. We also tested NE in the same doses 
as EPI to understand if its peripheral action in contextual-fear memory is similar 
or not. Another aim was to understand if β2-AD antagonists could erase 
traumatic contextual memories. Finally, we propose a possible pharmacological 
therapy for traumatic memories in anxiety disorders, in particular PTSD. 
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Stress is an undisputed environmental risk factor for disease, in particular 
psychiatric diseases. The moment and the context of stressful stimuli are 
essential and determine the adaptive or maladaptive consequences (Schmidt 
2010). Adrenal stress hormones have an important role in encoding alarm 
signals to the brain. These hormones influence memory, in fact, it has been 
provided widespread evidence that EPI, NE and glucocorticoids modulate long-
term memory consolidation in humans (McGaugh and Roozendaal 2002). 
Pnmt-KO mice are EPI deficient mice and show impairment in contextual-fear 
memory (Toth et al. 2013), suggesting that these mice reveal selective memory 
effects on highly emotional memories. To understand this better we started to 
explore EPI role in fear memory. We showed that contextual aversive memories 
are better retained in the presence of moderately high plasma EPI 
concentrations. In Pnmt-KO mice, we also showed restored expression of 
contextual-fear memory after EPI, or non-selective β-AD agonist (isoprenaline) 
or selective β2-AD agonist (fenoterol) treatments. In addition, a selective β1-AD 
agonist (dobutamine) does not seem to increase freezing in Pnmt-KO mice. 
Moreover, treatment of Pnmt-KO mice with a peripheral β-AD antagonist 
(sotalol) (Alves et al. 2016) blocked the increased freezing induced by EPI. In 
addition, EPI (Weil-Malherbe et al. 1959), AD agonists (fenoterol, (Rominger 
and Pollmann 1972)) and antagonists (sotalol (Mason and Angel 1983)) used 
do not cross the blood-brain barrier. Therefore, we showed that EPI affects 
contextual-fear memory by acting on peripheral β2-ADs. 
Glucose is a limited source of energy. It appears that EPI acts on hepatic 
glucose production by stimulation of glycogenolysis and gluconeogenesis (John 
et al. 1990). In addition, we showed that EPI restores the glycemic response at 
the same time as contextual-fear memory in Pnmt-KO mice (Alves et al. 2016). 
Since glucose crosses the blood–brain barrier, it may modulate memory (Gold 
et al. 1986). John et al. also showed that a β-AD agonist (isoprenaline) 
improves the hyperglycemic response and this was blocked by a selective β2-
AD antagonist (ICI 118,551) (John et al. 1990). Glucose may be a chief down-
stream intermediary of EPI actions in contextual memory. In fact, it was shown 
that a surge in plasma glucose increases acetylcholine synthesis in the 
hippocampus (Durkin et al. 1992), providing supplementary energy to specific 
neural components, and modulate neuronal excitability and neurotransmitter 
CHAPTER 5 - DISCUSSION AND FUTURE PERSPECTIVES 
 
78 
 
release (McNay and Gold 2002). Therefore the evaluation of acetylcholine 
synthesis and neurotransmitter release after fear conditioning procedure in 
Pnmt-KO and WT mice could be the next step to better understand this 
mechanism. In addition, the quantification of specific proteins in hippocampus 
would be interesting, since modulation of gene expression seems to be a 
requirement of consolidation and persistence of long-term memories, and may 
result in synaptic remodeling (Dudai 2006). 
In both mice and humans, β-ADs selectively affect contextual-fear memory, and 
not auditory fear learning (Alves et al. 2016; Grillon et al. 2004; Toth et al. 
2013). The pathways for contextual and auditory learning seem different. 
Cellular mechanisms whereby contextual-fear memory consolidation occurs are 
connected to the hippocampus and the amygdala, whereas tone conditioning 
only depends on amygdala molecular plastic changes (Phillips and LeDoux 
1992). 
The classic fight-or-flight response to aversive stimulus has clear survival 
benefits in evolutionary terms. However, the systems responsible to the 
perceived threat can become deregulated under some circumstances. Chronic 
deregulation of these systems can lead to PTSD (Sherin and Nemeroff 2011). 
PTSD is a psychopathological response to extreme stressors. It is characterized 
by the intrusive re-experiencing of the traumas and heightened physiological 
arousal with noticeable anxiety and depressive features persisting for at least 
one month. Only a percentage of those exposed to fear-producing events 
develop or sustain PTSD (Yehuda et al. 1998). PTSD can be a limitation to an 
organized life routine. There is a considerable amount of work being done to 
find new approaches for delivering evidence-based treatments for PTSD, such 
as exposure and cognitive therapy. However, the efficacy of these treatments 
has been limited (Kaczkurkin and Foa 2015). 
There are also several pharmacotherapies for treating PTSD. Serotonin 
reuptake inhibitors are the most frequently prescribed pharmacological agents 
for the treatment of PTSD, as they are reasonably well tolerated and safe. 
However, they have innumerous limitations. The beginning of the therapeutic 
effect usually takes several weeks to occur, sometimes there are remaining 
symptoms, or non-response, as well as persistent undesirable side effects, such 
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as changes in appetite and weight, gastrointestinal disturbances, and loss of 
sexual drive (Kelmendi et al. 2016). 
Hidrocortisone shortly after exposure to psychological trauma is thought to be 
effective in PTSD (de Quervain and Margraf 2008), by exerting negative 
feedback control of the hypothalamic-pituitary-adrenal axis. However, sustained 
glucocorticoid exposure has huge adverse effects in the brain and metabolism. 
In fact, continued glucocorticoid exposure induces the decline of dendritic 
branching, damage of dendritic spines and impairment of neurogenesis in 
hippocampus (Sherin and Nemeroff 2011). 
Patients with PTSD manifest greater changes in heart rate, blood pressure, and 
skin conductance than controls, when exposed to trauma-related contexts. In 
fact, a persistent hyperactivity of autonomic sympathetic system was detected. 
Accordingly, increased urinary excretion of catecholamines and their 
metabolites, as well as, increase of EPI in plasma has been documented in 
PTSD (Shalev et al. 1992; Sherin and Nemeroff 2011). 
In healthy humans, propranolol (peripheral and central acting β-AD antagonist) 
has been found to weaken the consolidation of contextual-fear memory in fear 
conditioning procedure. Therefore, similarly to mice, in humans, β-ADs are also 
implicated in contextual-fear conditioning (Grillon et al. 2004). In addition, 
altered amygdala and hippocampus activity, evaluated by functional magnetic 
resonance, is related with propranolol-induced emotional memory weakening in 
healthy individuals (Schwabe et al. 2012). 
Administration of propranolol soon after exposure to psychological trauma has 
been described to reduce PTSD symptoms severity and reactivity to trauma 
cues, and may even prevent PTSD development (Brunet et al. 2008; Pitman et 
al. 2002). Reconsolidation theory defends that in order to endure, a recalled 
memory needs to be saved again to long-term memory storage, thereby 
recapitulating the process of memory consolidation. Propranolol appears to 
block consolidation and even reconsolidation, allowing the attenuation of 
emotional strength of traumatic memories (Lonergan et al. 2013). A PTSD 
remission of up 71 % was detected after six sessions of trauma recollection 
under the effect of propranolol (Brunet et al. 2011), with a significant decrease 
in physiological reacting to context cues, at 6 month follow-up (Brunet et al. 
2014). 
CHAPTER 5 - DISCUSSION AND FUTURE PERSPECTIVES 
 
80 
 
In mice, there are evidences that fear memory lasts for a long-term, even 
months (old memories) (McGaugh and Roozendaal 2002). On the other hand, 
we showed that fear memory may be conducted by EPI peripheral pathway 
trough β2-ADs (Alves et al. 2016). In addition, our results show that this 
mechanism persists in the long-term (one day after fear acquisition) and even 
as old memories (one month after fear acquisition), by blocking freezing in 
Pnmt-KO EPI treated mice and in WT mice, with a β2-AD antagonist (ICI 
118,551). Thus, β2-AD activation by EPI seems to be an important pathway for 
both short and long-term fear memory, and even old memories. In addition, 
propranolol administered systemically after retrieval (through contextual 
reactivation) disrupts contextual-fear memory reconsolidation, being a possible 
therapeutic treatment in PTSD (Muravieva and Alberini 2010). However, 
propranolol has significant secondary effects (fatigue, bradycardia, Raynaud 
phenomenon, sleep and gastrointestinal disturbances…). In addition, 
propranolol decreased memory consolidation in non-aversive tasks (object 
recognition and object location) and weakened memory reconsolidation not only 
in most, but also in least aversive tasks (Villain et al. 2016). Therefore, we 
suggest that β2-AD antagonists may be a more successful treatment in anxiety 
diseases, particularly in PSTD. The efficacy of β2-AD antagonists could be 
evaluated in contextual fear memory, of a PTSD mice model. To disrupt 
traumatic memories that may contribute to the development of PTSD, we could 
interfere with the reconsolidation process (Dudai 2006), though the 
administration of a β2-AD antagonist (ICI 118,551 or one that does not pass the 
blood-brain barrier) after retrieval, though contextual reactivation. 
In conclusion, EPI increases in plasma after an aversive experience, possibly 
improving long-term contextual fear memory, and even old memories, by acting 
on peripheral β2-ADs. We suggest that blocking β2-ADs with antagonists may 
inhibit undesirable memories, and be used as a treatment for patients suffering 
from pathogenic memories, such as PTSD. 
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